Furthermore, emerging evidence has shown that several biomarkers are sensitive, specific, and causally related with regards to the early prediction or risk assessment of AKI, including neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty-acid binding protein (L-FABP) [11,12,13,14,15]. This evidence concerns the gene LCN2 and acute kidney injury.